Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 5,571 | N/A | N/A |
| Receivables | 440 | N/A | N/A |
| TOTAL | $6,106 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 209 | N/A | N/A |
| Investments And Advances | 999 | 0 | 0 |
| Other Non-Current Assets | 4,572 | 0 | 0 |
| TOTAL | $5,780 | $N/A | $N/A |
| Total Assets | $11,886 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 11,239 | 0 | 0 |
| Accrued Expenses | 2,661 | N/A | N/A |
| Other current liabilities | 5,794 | N/A | N/A |
| TOTAL | $26,575 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 3,897 | 0 | 0 |
| TOTAL | $3,897 | $N/A | $N/A |
| Total Liabilities | $30,472 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 148 | N/A | N/A |
| Retained earnings | -80,455 | N/A | N/A |
| Other shareholders' equity | 190 | 0 | 0 |
| TOTAL | $-18,586 | $N/A | $N/A |
| Total Liabilities And Equity | $11,886 | $0 | $0 |